Factor VIII (Tonrol Biopharmaceuticals)

凝血因子 VIII（同路生物制药有限公司）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFactor VIII (Tonrol Biopharmaceuticals)

Drug Alias NameHEMORAASHemorass

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor

Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation

TargetsCoagulation factor X

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsHemophilia A

Inactive IndicationsN/A

ATC CodeB02BD02